Stockhead on MSN
Orthocell flags rapid ‘hockey stick’ revenue growth in US$1.6 billion US nerve repair market
Nerve repair house Orthocell is thrilled about the rollout of its flagship Remplir device in the US and expects revenue to grow sharply.
Dr. Linda Girgis provides insightful commentary on a recent New York Times article, “Are AI Tools Making Doctors Worse at ...
A $100,000 fee for H-1B visas will particularly affect physicians trained in India who the U.S. can't afford to lose, writes ...
Stereotactic body radiation therapy (SBRT), defined as the delivery of >5Gy per fraction, has emerged as a well-established standard of care option for the definitive management of localized prostate ...
Find out how robotic technology for knee replacement surgery at Southlake Health is delivering personalized and precise care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results